Filing Details

Accession Number:
0001104659-20-139953
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-28 21:03:30
Reporting Period:
2020-12-22
Accepted Time:
2020-12-28 21:03:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1737953 Replimune Group Inc. REPL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376492 Robert Coffin C/O Replimune Group, Inc.
500 Unicorn Park
Woburn MA 01801
President & Chief R&D Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-22 220,000 $40.04 1,804,118 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 16, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
  2. Following the sales reported on this Form 4, the reporting person continues to beneficially own 1,804,118 shares of the Issuer's common stock. The reporting person also holds options to acquire 977,599 shares of the Issuer's common stock, 468,928 of which are exercisable as of the date hereof.